| 000 | 01745 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518043515.0 | ||
| 264 | 0 | _c20200622 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1098-6596 | ||
| 024 | 7 |
_a10.1128/AAC.00060-19 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHanboonkunupakarn, Borimas | |
| 245 | 0 | 0 |
_aSequential Open-Label Study of the Safety, Tolerability, and Pharmacokinetic Interactions between Dihydroartemisinin-Piperaquine and Mefloquine in Healthy Thai Adults. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _c08 2019 |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntimalarials _xadverse effects |
| 650 | 0 | 4 |
_aArtemisinins _xadverse effects |
| 650 | 0 | 4 |
_aCardiotoxicity _xetiology |
| 650 | 0 | 4 |
_aDizziness _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHealthy Volunteers |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMefloquine _xadverse effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNausea _xchemically induced |
| 650 | 0 | 4 |
_aQuinolines _xadverse effects |
| 650 | 0 | 4 | _aThailand |
| 700 | 1 | _avan der Pluijm, Rob W | |
| 700 | 1 | _aHoglund, Richard | |
| 700 | 1 | _aPukrittayakamee, Sasithon | |
| 700 | 1 | _aWinterberg, Markus | |
| 700 | 1 | _aMukaka, Mavuto | |
| 700 | 1 | _aWaithira, Naomi | |
| 700 | 1 | _aChotivanich, Kesinee | |
| 700 | 1 | _aSinghasivanon, Pratap | |
| 700 | 1 | _aWhite, Nicholas J | |
| 700 | 1 | _aDondorp, Arjen M | |
| 700 | 1 | _aTarning, Joel | |
| 700 | 1 | _aJittamala, Podjanee | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 63 _gno. 8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.00060-19 _zAvailable from publisher's website |
| 999 |
_c29782230 _d29782230 |
||